19.89
0.45%
0.09
After Hours:
19.89
Singular Genomics Systems Inc stock is traded at $19.89, with a volume of 6,620.
It is up +0.45% in the last 24 hours and up +1.27% over the past month.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
See More
Previous Close:
$19.80
Open:
$19.89
24h Volume:
6,620
Relative Volume:
0.32
Market Cap:
$50.46M
Revenue:
$2.91M
Net Income/Loss:
$-94.82M
P/E Ratio:
-15.30
EPS:
-1.3
Net Cash Flow:
$-74.62M
1W Performance:
+0.20%
1M Performance:
+1.27%
6M Performance:
+145.71%
1Y Performance:
+32.60%
Singular Genomics Systems Inc Stock (OMIC) Company Profile
Name
Singular Genomics Systems Inc
Sector
Industry
Phone
(858) 333-7830
Address
3010 SCIENCE PARK ROAD, SAN DIEGO
Compare OMIC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
OMIC
Singular Genomics Systems Inc
|
19.89 | 50.46M | 2.91M | -94.82M | -74.62M | -1.30 |
ISRG
Intuitive Surgical Inc
|
580.18 | 206.65B | 8.35B | 2.32B | 586.00M | 6.41 |
BDX
Becton Dickinson Co
|
248.49 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
92.32 | 45.66B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
257.65 | 37.85B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
343.91 | 24.95B | 2.88B | 499.60M | 321.60M | 6.74 |
Singular Genomics Systems Inc Stock (OMIC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-17-22 | Downgrade | UBS | Buy → Neutral |
Aug-10-22 | Downgrade | BofA Securities | Buy → Underperform |
Aug-10-22 | Downgrade | Goldman | Buy → Neutral |
Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
Oct-15-21 | Resumed | Cowen | Outperform |
Singular Genomics Systems Inc Stock (OMIC) Latest News
OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm - PR Newswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, OMIC, NEUE, RSLS on Behalf of Shareholders - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, AMCR, ZUO on Behalf of Shareholders - The Bakersfield Californian
SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc.OMIC - Business Wire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerBERY, OMIC, EMKR, AMCR - Finansavisen
OMIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Singular Genomics Systems, Inc. Is Fair to Shareholders - Business Wire
Geode Capital Management LLC Boosts Stake in Singular Genomics Systems, Inc. (NASDAQ:OMIC) - Defense World
Singular Genomics Systems (NASDAQ:OMIC) Trading Up 0.9% – Should You Buy? - Defense World
(OMIC) Technical Data - Stock Traders Daily
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA, LBRDA on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates OMIC, MRNS, VCSA on Behalf of Shareholders - GlobeNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of SunLink Health Systems, Inc.SSY - cnhinews.com
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – NEUE, OMIC, JWN, DESP - GlobeNewswire Inc.
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerNEUE, OMIC, JWN, DESP - Markets Insider
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Singular Genomics Systems, Inc.OMIC - The Malaysian Reserve
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, OMIC, LTRPA on Behalf of Shareholders - GlobeNewswire
Singular Genomics to be acquired by Deerfield for $20.00 per share in case - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VOXX, JWN, OMIC, LTRPA on Behalf of Shareholders - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, USAP, NBR on Behalf of Shareholders - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, STAF, ALVR on Behalf of Shareholders - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PDCO, NURO, PWOD, CARA on Behalf of Shareholders - cnhinews.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Singular Genomics Systems, Inc. (NasdaqOMIC), Nordstrom, Inc. (NYSEJWN), Despegar.com, Corp. (NYSEDESP), Patterson Companies, Inc. (Nasdaq - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations - The Bakersfield Californian
Shareholder Alert: Ademi LLP Investigates Whether Singular Genomics Systems, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Singular Genomics Systems Agrees to Be Acquired By Deerfield Management for $20 per Share - Marketscreener.com
Deerfield to Take Singular Genomics Private in $50.2M Deal - MarketWatch
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share - The Manila Times
Singular Genomics Agrees to $20/Share BuyoutDeerfield Offers Massive 254% Premium in Take-Private Deal - StockTitan
Singular genomics CEO sells stock for $3,629 By Investing.com - Investing.com South Africa
Singular genomics CEO sells stock for $3,629 - Investing.com India
Trading (OMIC) With Integrated Risk Controls - Stock Traders Daily
Singular Genomics Systems (NASDAQ:OMIC) Trading Up 3.2%What's Next? - MarketBeat
Singular Genomics Systems (NASDAQ:OMIC) Stock Price Up 3.2% – Still a Buy? - Defense World
Lumos Pharma enters into definitive merger agreement with Double Point Ventures to go private via tender offer - substack.com
(OMIC) Investment Report - Stock Traders Daily
OMICSingular Genomics Systems, Inc. Latest Stock News & Market Updates - StockTitan
Genomic Testing Market Poised to Reach Valuation of US$ 32.95 Billion By 2032 | Astute Analytica - GlobeNewswire
CRCM LP Reduces Stake in Singular Genomics Systems Inc - GuruFocus.com
(OMIC) Trading Advice - Stock Traders Daily
Short Interest in Singular Genomics Systems, Inc. (NASDAQ:OMIC) Drops By 18.9% - MarketBeat
Singular Genomics CEO Andrew Spaventa sells $15,668 in stock - Investing.com India
Singular Genomics Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Singular Genomics CEO Andrew Spaventa sells $15,668 in stock By Investing.com - Investing.com Canada
Sparkline Intangible Value ETF (NYSEARCA:ITAN) Stock Price Down 0.5% – Time to Sell? - Defense World
Gusbourne (OTCMKTS:SLLFF) Stock Price Down 19.6% – Here’s Why - Defense World
Singular Genomics Systems (NASDAQ:OMIC) Trading Up 0.4%Here's Why - MarketBeat
Similar Genomics Systems: Q3 Earnings Snapshot - The Washington Post
Singular Genomics Systems Inc Stock (OMIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):